Abstract
Clinical study data and postmarket surveillance data on intrathecal drug delivery and spinal cord stimulation device infections were reviewed along with selected literature pertaining to cerebrospinal fluid shunt, implantable cardiac pacemaker, and surgical site infections. Most infections begin at the time of device implantation. Treatment typically involves antibiotic administration and device explantation. Available evidence suggests that the incidence of infection can be minimized by the use of published guidelines.
| Original language | English (US) |
|---|---|
| Pages (from-to) | 1582-1594 |
| Number of pages | 13 |
| Journal | Anesthesiology |
| Volume | 100 |
| Issue number | 6 |
| DOIs | |
| State | Published - Jun 1 2004 |
ASJC Scopus subject areas
- Anesthesiology and Pain Medicine
Fingerprint Dive into the research topics of 'Prevention and management of intrathecal drug delivery and spinal cord stimulation system infections'. Together they form a unique fingerprint.
Cite this
Follett, K. A., Boortz-Marx, R. L., Drake, J. M., DuPen, S., Schneider, S. J., Turner, M. S., & Coffey, R. J. (2004). Prevention and management of intrathecal drug delivery and spinal cord stimulation system infections. Anesthesiology, 100(6), 1582-1594. https://doi.org/10.1097/00000542-200406000-00034